![]() IMP to be used in the trial has a marketing authorisation Status of the IMP to be used in the clinical trial Trial is part of a Paediatric Investigation PlanĮMA Decision number of Paediatric Investigation Plan Name or abbreviated title of the trial where available non-technical, languageĪDAPTIVE EFFICACY AND SAFETY STUDY OF GLENZOCIMAB USED AS AN ADD-ON THERAPY ON TOP OF STANDARD OF CARE IN THE 4.5 HOURS FOLLOWING AN ACUTE ISCHEMIC STROKEĮSTUDIO DE SEGURIDAD Y EFICACIA ADAPTATIVA DE GLENZOCIMAB UTILIZADO COMO TERAPIA ADICIONAL ADEMÁS DEL ESTÁNDAR DE ATENCIÓN EN LAS 4.5 HORAS DESPUÉS DE UN ICTUS ISQUÉMICO AGUDO Title of the trial for lay people, in easily understood, i.e. Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (seeĪ RANDOMIZED, DOUBLE BLIND, MULTICENTER, MULTINATIONAL, PLACEBO CONTROLLED, PARALLEL GROUP, SINGLE DOSE, ADAPTIVE EFFICACY AND SAFETY STUDY OF GLENZOCIMAB USED AS AN ADD-ON THERAPY ON TOP OF STANDARD OF CARE IN THE 4.5 HOURS FOLLOWING AN ACUTE ISCHEMIC STROKEĮSTUDIO ALEATORIZADO, MULTICÉNTRICO Y MULTINACIONAL, CON DOBLE ENMASCARAMIENTO Y CONTROLADO CON PLACEBO, CON GRUPOS PARALELOS, DE DOSIS ÚNICA Y DISEÑO ADAPTATIVO PARA EVALUAR LA EFICACIA Y SEGURIDAD DEL GLENZOCIMAB UTILIZADO COMO TRATAMIENTO COMPLEMENTARIO AL TRATAMIENTO HABITUAL EN LAS 4,5 HORAS SIGUIENTES A UN ICTUS ISQUÉMICO AGUDO ![]() Older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006). ![]() The register also displays information on The EU Clinical Trials Register currently displaysĬlinical trials with a EudraCT protocol, of whichĪre clinical trials conducted with subjects less than 18 years old. Interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/ECĬlinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine developmentĮU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through theĬlinical Trials Information System (CTIS). Allows you to search for protocol and results information on: ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |